Science, organized and continuously updated.
A central resource for scientific publications, studies, white papers, presentations, posters, videos, patents, and clinical collaborations.
Selected work shaping the platform.
Curated publications and technical papers that anchor current programs across regenerative biology, device engineering, and evidence generation.
Improvements in Diabetic Neuropathy with Topical Human Mesenchymal Stem Cell Conditioned Media
Pilot study of a topical mesenchymal stem cell media–conditioned cream (Neurocream) applied twice daily to the soles of the feet after brief micro-needling in type-2 diabetic and non-diabetic patients with progressive neuropathy. T2D participants reported approximately a 50% average reduction across foot pain, tingling, and swelling at 30 days; non-T2D participants reported a 57% reduction in swelling and 40% reduction in foot pain. All participants reported improved sleep.
Reduction in Age-Related Skin Damage Using Products Incorporating Novel Topical Human Mesenchymal Stem Cell Conditioned Media
Pilot clinical trial (n=12) evaluating a topical stem cell–conditioned skin cream applied over eight weeks to address age-related skin concerns including tone, texture, brightness, and fine lines. Discussion covers the biology of skin senescence, paracrine signaling by MSCs, and the growth-factor and cytokine cargo underlying observed improvements in skin aesthetics.
Exosomes; a Potential Source of Biomarkers, Therapy, and Cure for Type-1 Diabetes
Comprehensive review of exosome biology across biomarker discovery, therapeutic delivery, and disease-modifying strategies in type-1 diabetes. Covers exosome biogenesis, cargo-mediated cellular crosstalk, autoimmune pathways in β-cell dysfunction, and the translational path toward exosome-based diagnostics and therapies, with implications for type-2 diabetes as well.
Design Considerations for Connected Regenerative Delivery Devices
Architectural considerations for building traceable, evidence-ready device systems intended for regenerative delivery, including consumable authentication, telemetry, and audit paths.
Most recently added to the library.
Architectural considerations for building traceable, evidence-ready device systems intended for regenerative delivery, including consumable authentication, telemetry, and audit paths.
Regulatory-classification considerations for connected regenerative medical device platforms, mapping features to expected review pathways.
A standardized protocol template supporting investigator-initiated studies aligned with the 4th State Medical evidence framework.
Conference presentation outlining the integrated regenerative platform thesis and near-term milestones.
Browse by research area.
Search and filter every entry.
Architectural considerations for building traceable, evidence-ready device systems intended for regenerative delivery, including consumable authentication, telemetry, and audit paths.
Regulatory-classification considerations for connected regenerative medical device platforms, mapping features to expected review pathways.
A standardized protocol template supporting investigator-initiated studies aligned with the 4th State Medical evidence framework.
Conference presentation outlining the integrated regenerative platform thesis and near-term milestones.
System and methods for authenticating single-use consumables in a connected regenerative delivery platform, including cryptographic pairing and use-count enforcement.
An introduction to 4th State Medical and its integrated regenerative technology platform.
Single-center 30-day clinical study (n=15, ages 18–43) of a topical acne product combining stem cell–conditioned media with salicylic acid. Analysis showed a statistically significant improvement in overall acne lesion appearance from baseline at day 30 (p=0.004) and strong participant-reported improvements in skin texture, with a favorable safety profile.
Pilot clinical trial (n=12) evaluating a topical stem cell–conditioned skin cream applied over eight weeks to address age-related skin concerns including tone, texture, brightness, and fine lines. Discussion covers the biology of skin senescence, paracrine signaling by MSCs, and the growth-factor and cytokine cargo underlying observed improvements in skin aesthetics.
A methodology summary for evaluating delivery systems across relevant preclinical models, including endpoints, controls, and reporting standards.
Validation of a combinational cryoprotectant strategy using lower-than-conventional concentrations of two permeating agents (DMSO and ethylene glycol) with a stepwise sucrose dilution during recovery. The optimized protocol yielded significantly higher post-thaw MSC viability (~80%) versus conventional DMSO-only approaches, supporting more effective banking of stem cells for downstream therapeutic use.
Pilot study of a topical mesenchymal stem cell media–conditioned cream (Neurocream) applied twice daily to the soles of the feet after brief micro-needling in type-2 diabetic and non-diabetic patients with progressive neuropathy. T2D participants reported approximately a 50% average reduction across foot pain, tingling, and swelling at 30 days; non-T2D participants reported a 57% reduction in swelling and 40% reduction in foot pain. All participants reported improved sleep.
Comprehensive review of exosome biology across biomarker discovery, therapeutic delivery, and disease-modifying strategies in type-1 diabetes. Covers exosome biogenesis, cargo-mediated cellular crosstalk, autoimmune pathways in β-cell dysfunction, and the translational path toward exosome-based diagnostics and therapies, with implications for type-2 diabetes as well.